Science Explorer Back to mapMap
Discussion
Researcher · Antalya IVF · Türkiye

Seda Irmak Öztürkmen

Seda Irmak Öztürkmen publishes mostly in Hematology, Oncology and Genetics, on topics such as Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research and Immunodeficiency and Autoimmune Disorders.

ORCID 0000-0002-6713-0147 OpenAlex
World rank
#5,642,582
of 7,710,434 ranked researchers
Rank in Türkiye
#60,030
of 117,622
Works
49
Citations
333
Citations per work
6.8
h-index
11
i10-index 11Top 54% in Hematology
Seda Irmak Öztürkmen

What does Seda Irmak Öztürkmen research?

Seda Irmak Öztürkmen's work is mostly in Medicine (48%), Immunology and Microbiology (6%).

Health Sciences: 23 works · 47.6% of their workMedicine: 23 works · 47.6% of their workHematology: 11 works · 21.7% of their workOncology: 4 works · 7.7% of their workGenetics: 3 works · 7.0% of their workPhysiology: 3 works · 5.6% of their workPublic Health, Environmental and Occupational Health: 3 works · 5.6% of their workEverything else: 23 works · 46.1% of their workLife Sciences: 3 works · 6.3% of their workImmunology and Microbiology: 3 works · 6.3% of their workImmunology: 3 works · 6.3% of their workTHEIR WORKSeda IrmakÖztürkmen49works
Life Sciences6%Health Sciences48%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2347.6%
  2. Everything else2346.1%
    1. Immunology and Microbiology36.3%
  1. 1Hematology22% of their works
  2. 2Oncology8% of their works
  3. 3Genetics7% of their works
  4. 4Immunology6% of their works
  5. 5Physiology6% of their works
  6. 6Public Health, Environmental and Occupational Health6% of their works

Research topics

Which keywords describe Seda Irmak Öztürkmen's research?

The keywords of their largest research topics: Hematopoietic Stem Cells, Bone Marrow Niche, Graft-versus-Host Disease, Prognostic Factors, Genetic Mutations, Acute Lymphoblastic Leukemia, Childhood Cancer and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Hematopoietic Stem Cells303 topics
  2. Bone Marrow Niche191 topic
  3. Graft-versus-Host Disease191 topic
  4. Prognostic Factors132 topics
  5. Genetic Mutations112 topics
  6. Acute Lymphoblastic Leukemia71 topic
  7. Childhood Cancer71 topic
  8. AML61 topic
  9. Acute Myeloid Leukemia61 topic
  10. Immune Dysregulation61 topic
  11. Primary Immunodeficiency61 topic
  12. Congenital Disorders51 topic
  13. Kidney Transplantation51 topic
  14. Neutropenia51 topic
  15. Renal Allograft51 topic
  16. Sickle-cell Disease51 topic
  17. Thalassemia51 topic
  18. Antimicrobial Agents41 topic
  19. Febrile Neutropenia41 topic

Where does Seda Irmak Öztürkmen work?

Seda Irmak Öztürkmen's main affiliation in the publication record is Antalya IVF, Türkiye.

How many publications and citations does Seda Irmak Öztürkmen have?

OpenAlex counts 49 works and 333 citations for Seda Irmak Öztürkmen, an h-index of 11, ranking #5,642,582 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Seda Irmak Öztürkmen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.